IBDEI0DO ; ; 03-MAY-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,34300,2)
;;=^5159288
;;^UTILITY(U,$J,358.3,34301,0)
;;=G44.1^^105^1431^10
;;^UTILITY(U,$J,358.3,34301,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34301,1,3,0)
;;=3^Vascular Headache NEC
;;^UTILITY(U,$J,358.3,34301,1,4,0)
;;=4^G44.1
;;^UTILITY(U,$J,358.3,34301,2)
;;=^5003934
;;^UTILITY(U,$J,358.3,34302,0)
;;=G43.909^^105^1431^6
;;^UTILITY(U,$J,358.3,34302,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34302,1,3,0)
;;=3^Migraine,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,34302,1,4,0)
;;=4^G43.909
;;^UTILITY(U,$J,358.3,34302,2)
;;=^5003909
;;^UTILITY(U,$J,358.3,34303,0)
;;=G44.009^^105^1431^1
;;^UTILITY(U,$J,358.3,34303,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34303,1,3,0)
;;=3^Cluster Headache,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,34303,1,4,0)
;;=4^G44.009
;;^UTILITY(U,$J,358.3,34303,2)
;;=^5003921
;;^UTILITY(U,$J,358.3,34304,0)
;;=G44.40^^105^1431^5
;;^UTILITY(U,$J,358.3,34304,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34304,1,3,0)
;;=3^Medication Overuse Headache,Not Intractable
;;^UTILITY(U,$J,358.3,34304,1,4,0)
;;=4^G44.40
;;^UTILITY(U,$J,358.3,34304,2)
;;=^5003947
;;^UTILITY(U,$J,358.3,34305,0)
;;=G44.89^^105^1431^2
;;^UTILITY(U,$J,358.3,34305,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34305,1,3,0)
;;=3^Headache Syndrome NEC
;;^UTILITY(U,$J,358.3,34305,1,4,0)
;;=4^G44.89
;;^UTILITY(U,$J,358.3,34305,2)
;;=^5003954
;;^UTILITY(U,$J,358.3,34306,0)
;;=G44.84^^105^1431^8
;;^UTILITY(U,$J,358.3,34306,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34306,1,3,0)
;;=3^Primary Exertional Headache
;;^UTILITY(U,$J,358.3,34306,1,4,0)
;;=4^G44.84
;;^UTILITY(U,$J,358.3,34306,2)
;;=^336563
;;^UTILITY(U,$J,358.3,34307,0)
;;=G44.301^^105^1431^7
;;^UTILITY(U,$J,358.3,34307,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34307,1,3,0)
;;=3^Post-Traumatic Headache,Unspec,Intractable
;;^UTILITY(U,$J,358.3,34307,1,4,0)
;;=4^G44.301
;;^UTILITY(U,$J,358.3,34307,2)
;;=^5003941
;;^UTILITY(U,$J,358.3,34308,0)
;;=G44.209^^105^1431^9
;;^UTILITY(U,$J,358.3,34308,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34308,1,3,0)
;;=3^Tension-Type Headache,Unspec,Not Intractable
;;^UTILITY(U,$J,358.3,34308,1,4,0)
;;=4^G44.209
;;^UTILITY(U,$J,358.3,34308,2)
;;=^5003936
;;^UTILITY(U,$J,358.3,34309,0)
;;=R51.0^^105^1431^3
;;^UTILITY(U,$J,358.3,34309,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34309,1,3,0)
;;=3^Headache w/ Orthostatic Component,NEC
;;^UTILITY(U,$J,358.3,34309,1,4,0)
;;=4^R51.0
;;^UTILITY(U,$J,358.3,34309,2)
;;=^5159305
;;^UTILITY(U,$J,358.3,34310,0)
;;=R51.9^^105^1431^4
;;^UTILITY(U,$J,358.3,34310,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34310,1,3,0)
;;=3^Headache,Unspec
;;^UTILITY(U,$J,358.3,34310,1,4,0)
;;=4^R51.9
;;^UTILITY(U,$J,358.3,34310,2)
;;=^5159306
;;^UTILITY(U,$J,358.3,34311,0)
;;=I30.0^^105^1432^5
;;^UTILITY(U,$J,358.3,34311,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34311,1,3,0)
;;=3^Idiopathic Pericarditis,Acute Nonspec
;;^UTILITY(U,$J,358.3,34311,1,4,0)
;;=4^I30.0
;;^UTILITY(U,$J,358.3,34311,2)
;;=^5007157
;;^UTILITY(U,$J,358.3,34312,0)
;;=I34.8^^105^1432^6
;;^UTILITY(U,$J,358.3,34312,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34312,1,3,0)
;;=3^Mitral Valve Disorders,Nonrheumatic Other
;;^UTILITY(U,$J,358.3,34312,1,4,0)
;;=4^I34.8
;;^UTILITY(U,$J,358.3,34312,2)
;;=^5007172
;;^UTILITY(U,$J,358.3,34313,0)
;;=I34.0^^105^1432^13
;;^UTILITY(U,$J,358.3,34313,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34313,1,3,0)
;;=3^Nonrheumatic Mitral Valve Insufficiency
;;^UTILITY(U,$J,358.3,34313,1,4,0)
;;=4^I34.0
;;^UTILITY(U,$J,358.3,34313,2)
;;=^5007169
;;^UTILITY(U,$J,358.3,34314,0)
;;=I34.9^^105^1432^12
;;^UTILITY(U,$J,358.3,34314,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34314,1,3,0)
;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
;;^UTILITY(U,$J,358.3,34314,1,4,0)
;;=4^I34.9
;;^UTILITY(U,$J,358.3,34314,2)
;;=^5007173
;;^UTILITY(U,$J,358.3,34315,0)
;;=I34.2^^105^1432^7
;;^UTILITY(U,$J,358.3,34315,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34315,1,3,0)
;;=3^Nonrhematic Mitral Valve Stenosis
;;^UTILITY(U,$J,358.3,34315,1,4,0)
;;=4^I34.2
;;^UTILITY(U,$J,358.3,34315,2)
;;=^5007171
;;^UTILITY(U,$J,358.3,34316,0)
;;=I35.0^^105^1432^10
;;^UTILITY(U,$J,358.3,34316,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34316,1,3,0)
;;=3^Nonrheumatic Aortic Valve Stenosis
;;^UTILITY(U,$J,358.3,34316,1,4,0)
;;=4^I35.0
;;^UTILITY(U,$J,358.3,34316,2)
;;=^5007174
;;^UTILITY(U,$J,358.3,34317,0)
;;=I35.1^^105^1432^9
;;^UTILITY(U,$J,358.3,34317,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34317,1,3,0)
;;=3^Nonrheumatic Aortic Valve Insufficiency
;;^UTILITY(U,$J,358.3,34317,1,4,0)
;;=4^I35.1
;;^UTILITY(U,$J,358.3,34317,2)
;;=^5007175
;;^UTILITY(U,$J,358.3,34318,0)
;;=I35.2^^105^1432^11
;;^UTILITY(U,$J,358.3,34318,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34318,1,3,0)
;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
;;^UTILITY(U,$J,358.3,34318,1,4,0)
;;=4^I35.2
;;^UTILITY(U,$J,358.3,34318,2)
;;=^5007176
;;^UTILITY(U,$J,358.3,34319,0)
;;=I35.9^^105^1432^8
;;^UTILITY(U,$J,358.3,34319,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34319,1,3,0)
;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
;;^UTILITY(U,$J,358.3,34319,1,4,0)
;;=4^I35.9
;;^UTILITY(U,$J,358.3,34319,2)
;;=^5007178
;;^UTILITY(U,$J,358.3,34320,0)
;;=I38.^^105^1432^4
;;^UTILITY(U,$J,358.3,34320,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34320,1,3,0)
;;=3^Endocarditis,Valve Unspec
;;^UTILITY(U,$J,358.3,34320,1,4,0)
;;=4^I38.
;;^UTILITY(U,$J,358.3,34320,2)
;;=^40327
;;^UTILITY(U,$J,358.3,34321,0)
;;=I05.0^^105^1432^18
;;^UTILITY(U,$J,358.3,34321,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34321,1,3,0)
;;=3^Rheumatic Mitral Stenosis
;;^UTILITY(U,$J,358.3,34321,1,4,0)
;;=4^I05.0
;;^UTILITY(U,$J,358.3,34321,2)
;;=^5007041
;;^UTILITY(U,$J,358.3,34322,0)
;;=I05.8^^105^1432^19
;;^UTILITY(U,$J,358.3,34322,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34322,1,3,0)
;;=3^Rheumatic Mitral Valve Disease NEC
;;^UTILITY(U,$J,358.3,34322,1,4,0)
;;=4^I05.8
;;^UTILITY(U,$J,358.3,34322,2)
;;=^5007043
;;^UTILITY(U,$J,358.3,34323,0)
;;=I05.9^^105^1432^20
;;^UTILITY(U,$J,358.3,34323,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34323,1,3,0)
;;=3^Rheumatic Mitral Valve Disease,Unspec
;;^UTILITY(U,$J,358.3,34323,1,4,0)
;;=4^I05.9
;;^UTILITY(U,$J,358.3,34323,2)
;;=^5007044
;;^UTILITY(U,$J,358.3,34324,0)
;;=I07.1^^105^1432^21
;;^UTILITY(U,$J,358.3,34324,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34324,1,3,0)
;;=3^Rheumatic Tricuspid Insufficiency
;;^UTILITY(U,$J,358.3,34324,1,4,0)
;;=4^I07.1
;;^UTILITY(U,$J,358.3,34324,2)
;;=^5007048
;;^UTILITY(U,$J,358.3,34325,0)
;;=I07.9^^105^1432^22
;;^UTILITY(U,$J,358.3,34325,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34325,1,3,0)
;;=3^Rheumatic Tricuspid Valve Disease,Unspec
;;^UTILITY(U,$J,358.3,34325,1,4,0)
;;=4^I07.9
;;^UTILITY(U,$J,358.3,34325,2)
;;=^5007051
;;^UTILITY(U,$J,358.3,34326,0)
;;=I08.0^^105^1432^16
;;^UTILITY(U,$J,358.3,34326,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34326,1,3,0)
;;=3^Rheumatic Disorders of Mitral & Aortic Valves
;;^UTILITY(U,$J,358.3,34326,1,4,0)
;;=4^I08.0
;;^UTILITY(U,$J,358.3,34326,2)
;;=^5007052
;;^UTILITY(U,$J,358.3,34327,0)
;;=I09.89^^105^1432^17
;;^UTILITY(U,$J,358.3,34327,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34327,1,3,0)
;;=3^Rheumatic Heart Diseases NEC
;;^UTILITY(U,$J,358.3,34327,1,4,0)
;;=4^I09.89
;;^UTILITY(U,$J,358.3,34327,2)
;;=^5007060
;;^UTILITY(U,$J,358.3,34328,0)
;;=I47.1^^105^1432^24
;;^UTILITY(U,$J,358.3,34328,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34328,1,3,0)
;;=3^Supraventricular Tachycardia
;;^UTILITY(U,$J,358.3,34328,1,4,0)
;;=4^I47.1
;;^UTILITY(U,$J,358.3,34328,2)
;;=^5007223
;;^UTILITY(U,$J,358.3,34329,0)
;;=I48.0^^105^1432^15
;;^UTILITY(U,$J,358.3,34329,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34329,1,3,0)
;;=3^Paroxysmal Atrial Fibrillation
;;^UTILITY(U,$J,358.3,34329,1,4,0)
;;=4^I48.0
;;^UTILITY(U,$J,358.3,34329,2)
;;=^90473
;;^UTILITY(U,$J,358.3,34330,0)
;;=I49.5^^105^1432^23
;;^UTILITY(U,$J,358.3,34330,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34330,1,3,0)
;;=3^Sick Sinus Syndrome
;;^UTILITY(U,$J,358.3,34330,1,4,0)
;;=4^I49.5
;;^UTILITY(U,$J,358.3,34330,2)
;;=^110404
;;^UTILITY(U,$J,358.3,34331,0)
;;=I49.8^^105^1432^3
;;^UTILITY(U,$J,358.3,34331,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34331,1,3,0)
;;=3^Cardiac Arrhythmias
;;^UTILITY(U,$J,358.3,34331,1,4,0)
;;=4^I49.8
;;^UTILITY(U,$J,358.3,34331,2)
;;=^5007236
;;^UTILITY(U,$J,358.3,34332,0)
;;=I49.9^^105^1432^2
;;^UTILITY(U,$J,358.3,34332,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34332,1,3,0)
;;=3^Cardiac Arrhythmia,Unspec
;;^UTILITY(U,$J,358.3,34332,1,4,0)
;;=4^I49.9
;;^UTILITY(U,$J,358.3,34332,2)
;;=^5007237
;;^UTILITY(U,$J,358.3,34333,0)
;;=R00.1^^105^1432^1
;;^UTILITY(U,$J,358.3,34333,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34333,1,3,0)
;;=3^Bradycardia,Unspec
;;^UTILITY(U,$J,358.3,34333,1,4,0)
;;=4^R00.1
;;^UTILITY(U,$J,358.3,34333,2)
;;=^5019164
;;^UTILITY(U,$J,358.3,34334,0)
;;=I34.1^^105^1432^14
;;^UTILITY(U,$J,358.3,34334,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34334,1,3,0)
;;=3^Nonrheumatic Mitral Valve Prolapse
;;^UTILITY(U,$J,358.3,34334,1,4,0)
;;=4^I34.1
;;^UTILITY(U,$J,358.3,34334,2)
;;=^5007170
;;^UTILITY(U,$J,358.3,34335,0)
;;=D68.4^^105^1433^1
;;^UTILITY(U,$J,358.3,34335,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34335,1,3,0)
;;=3^Acquired Coagulation Factor Deficiency
;;^UTILITY(U,$J,358.3,34335,1,4,0)
;;=4^D68.4
;;^UTILITY(U,$J,358.3,34335,2)
;;=^2235
;;^UTILITY(U,$J,358.3,34336,0)
;;=D59.9^^105^1433^2
;;^UTILITY(U,$J,358.3,34336,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34336,1,3,0)
;;=3^Acquired Hemolytic Anemia,Unspec
;;^UTILITY(U,$J,358.3,34336,1,4,0)
;;=4^D59.9
;;^UTILITY(U,$J,358.3,34336,2)
;;=^5002330
;;^UTILITY(U,$J,358.3,34337,0)
;;=C91.00^^105^1433^5
;;^UTILITY(U,$J,358.3,34337,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34337,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,34337,1,4,0)
;;=4^C91.00
;;^UTILITY(U,$J,358.3,34337,2)
;;=^5001762
;;^UTILITY(U,$J,358.3,34338,0)
;;=C91.01^^105^1433^4
;;^UTILITY(U,$J,358.3,34338,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34338,1,3,0)
;;=3^Acute Lymphoblastic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,34338,1,4,0)
;;=4^C91.01
;;^UTILITY(U,$J,358.3,34338,2)
;;=^5001763
;;^UTILITY(U,$J,358.3,34339,0)
;;=C92.01^^105^1433^7
;;^UTILITY(U,$J,358.3,34339,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34339,1,3,0)
;;=3^Acute Myeloblastic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,34339,1,4,0)
;;=4^C92.01
;;^UTILITY(U,$J,358.3,34339,2)
;;=^5001790
;;^UTILITY(U,$J,358.3,34340,0)
;;=C92.00^^105^1433^8
;;^UTILITY(U,$J,358.3,34340,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34340,1,3,0)
;;=3^Acute Myeloblastic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,34340,1,4,0)
;;=4^C92.00
;;^UTILITY(U,$J,358.3,34340,2)
;;=^5001789
;;^UTILITY(U,$J,358.3,34341,0)
;;=C92.61^^105^1433^9
;;^UTILITY(U,$J,358.3,34341,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34341,1,3,0)
;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
;;^UTILITY(U,$J,358.3,34341,1,4,0)
;;=4^C92.61
;;^UTILITY(U,$J,358.3,34341,2)
;;=^5001808
;;^UTILITY(U,$J,358.3,34342,0)
;;=C92.60^^105^1433^10
;;^UTILITY(U,$J,358.3,34342,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34342,1,3,0)
;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
;;^UTILITY(U,$J,358.3,34342,1,4,0)
;;=4^C92.60
;;^UTILITY(U,$J,358.3,34342,2)
;;=^5001807
;;^UTILITY(U,$J,358.3,34343,0)
;;=C92.A1^^105^1433^11
;;^UTILITY(U,$J,358.3,34343,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34343,1,3,0)
;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
;;^UTILITY(U,$J,358.3,34343,1,4,0)
;;=4^C92.A1
;;^UTILITY(U,$J,358.3,34343,2)
;;=^5001814
;;^UTILITY(U,$J,358.3,34344,0)
;;=C92.A0^^105^1433^12
;;^UTILITY(U,$J,358.3,34344,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34344,1,3,0)
;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
;;^UTILITY(U,$J,358.3,34344,1,4,0)
;;=4^C92.A0
;;^UTILITY(U,$J,358.3,34344,2)
;;=^5001813
;;^UTILITY(U,$J,358.3,34345,0)
;;=C92.51^^105^1433^13
;;^UTILITY(U,$J,358.3,34345,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34345,1,3,0)
;;=3^Acute Myelomonocytic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,34345,1,4,0)
;;=4^C92.51
;;^UTILITY(U,$J,358.3,34345,2)
;;=^5001805
;;^UTILITY(U,$J,358.3,34346,0)
;;=C92.50^^105^1433^14
;;^UTILITY(U,$J,358.3,34346,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34346,1,3,0)
;;=3^Acute Myelomonocytic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,34346,1,4,0)
;;=4^C92.50
;;^UTILITY(U,$J,358.3,34346,2)
;;=^5001804
;;^UTILITY(U,$J,358.3,34347,0)
;;=C94.40^^105^1433^17
;;^UTILITY(U,$J,358.3,34347,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34347,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
;;^UTILITY(U,$J,358.3,34347,1,4,0)
;;=4^C94.40
;;^UTILITY(U,$J,358.3,34347,2)
;;=^5001843
;;^UTILITY(U,$J,358.3,34348,0)
;;=C94.42^^105^1433^15
;;^UTILITY(U,$J,358.3,34348,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34348,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
;;^UTILITY(U,$J,358.3,34348,1,4,0)
;;=4^C94.42
;;^UTILITY(U,$J,358.3,34348,2)
;;=^5001845
;;^UTILITY(U,$J,358.3,34349,0)
;;=C94.41^^105^1433^16
;;^UTILITY(U,$J,358.3,34349,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34349,1,3,0)
;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
;;^UTILITY(U,$J,358.3,34349,1,4,0)
;;=4^C94.41
;;^UTILITY(U,$J,358.3,34349,2)
;;=^5001844
;;^UTILITY(U,$J,358.3,34350,0)
;;=D62.^^105^1433^18
;;^UTILITY(U,$J,358.3,34350,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34350,1,3,0)
;;=3^Acute Posthemorrhagic Anemia
;;^UTILITY(U,$J,358.3,34350,1,4,0)
;;=4^D62.
;;^UTILITY(U,$J,358.3,34350,2)
;;=^267986
;;^UTILITY(U,$J,358.3,34351,0)
;;=C92.41^^105^1433^19
;;^UTILITY(U,$J,358.3,34351,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34351,1,3,0)
;;=3^Acute Promyelocytic Leukemia,In Remission
;;^UTILITY(U,$J,358.3,34351,1,4,0)
;;=4^C92.41
;;^UTILITY(U,$J,358.3,34351,2)
;;=^5001802
;;^UTILITY(U,$J,358.3,34352,0)
;;=C92.40^^105^1433^20
;;^UTILITY(U,$J,358.3,34352,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34352,1,3,0)
;;=3^Acute Promyelocytic Leukemia,Not in Remission
;;^UTILITY(U,$J,358.3,34352,1,4,0)
;;=4^C92.40
;;^UTILITY(U,$J,358.3,34352,2)
;;=^5001801
;;^UTILITY(U,$J,358.3,34353,0)
;;=D56.0^^105^1433^21
;;^UTILITY(U,$J,358.3,34353,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34353,1,3,0)
;;=3^Alpha Thalassemia
;;^UTILITY(U,$J,358.3,34353,1,4,0)
;;=4^D56.0
;;^UTILITY(U,$J,358.3,34353,2)
;;=^340494
;;^UTILITY(U,$J,358.3,34354,0)
;;=D63.1^^105^1433^23
;;^UTILITY(U,$J,358.3,34354,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34354,1,3,0)
;;=3^Anemia in Chronic Kidney Disease
;;^UTILITY(U,$J,358.3,34354,1,4,0)
;;=4^D63.1
;;^UTILITY(U,$J,358.3,34354,2)
;;=^332908
;;^UTILITY(U,$J,358.3,34355,0)
;;=D63.0^^105^1433^24
;;^UTILITY(U,$J,358.3,34355,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34355,1,3,0)
;;=3^Anemia in Neoplastic Disease
;;^UTILITY(U,$J,358.3,34355,1,4,0)
;;=4^D63.0
;;^UTILITY(U,$J,358.3,34355,2)
;;=^321978
;;^UTILITY(U,$J,358.3,34356,0)
;;=D63.8^^105^1433^22
;;^UTILITY(U,$J,358.3,34356,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34356,1,3,0)
;;=3^Anemia in Chronic Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,34356,1,4,0)
;;=4^D63.8
;;^UTILITY(U,$J,358.3,34356,2)
;;=^5002343
;;^UTILITY(U,$J,358.3,34357,0)
;;=C22.3^^105^1433^27
;;^UTILITY(U,$J,358.3,34357,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34357,1,3,0)
;;=3^Angiosarcoma of Liver
;;^UTILITY(U,$J,358.3,34357,1,4,0)
;;=4^C22.3
;;^UTILITY(U,$J,358.3,34357,2)
;;=^5000936
;;^UTILITY(U,$J,358.3,34358,0)
;;=D61.9^^105^1433^28
;;^UTILITY(U,$J,358.3,34358,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34358,1,3,0)
;;=3^Aplastic Anemia,Unspec
;;^UTILITY(U,$J,358.3,34358,1,4,0)
;;=4^D61.9
;;^UTILITY(U,$J,358.3,34358,2)
;;=^5002342
;;^UTILITY(U,$J,358.3,34359,0)
;;=D56.1^^105^1433^34
;;^UTILITY(U,$J,358.3,34359,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34359,1,3,0)
;;=3^Beta Thalassemia
;;^UTILITY(U,$J,358.3,34359,1,4,0)
;;=4^D56.1
;;^UTILITY(U,$J,358.3,34359,2)
;;=^340495
;;^UTILITY(U,$J,358.3,34360,0)
;;=C83.79^^105^1433^36
;;^UTILITY(U,$J,358.3,34360,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34360,1,3,0)
;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,34360,1,4,0)
;;=4^C83.79
;;^UTILITY(U,$J,358.3,34360,2)
;;=^5001600
;;^UTILITY(U,$J,358.3,34361,0)
;;=C83.70^^105^1433^37
;;^UTILITY(U,$J,358.3,34361,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34361,1,3,0)
;;=3^Burkitt Lymphoma,Unspec Site
;;^UTILITY(U,$J,358.3,34361,1,4,0)
;;=4^C83.70
;;^UTILITY(U,$J,358.3,34361,2)
;;=^5001591
;;^UTILITY(U,$J,358.3,34362,0)
;;=D09.0^^105^1433^44
;;^UTILITY(U,$J,358.3,34362,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34362,1,3,0)
;;=3^Carcinoma in Situ of Bladder
;;^UTILITY(U,$J,358.3,34362,1,4,0)
;;=4^D09.0
;;^UTILITY(U,$J,358.3,34362,2)
;;=^267742
;;^UTILITY(U,$J,358.3,34363,0)
;;=D06.9^^105^1433^45
;;^UTILITY(U,$J,358.3,34363,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34363,1,3,0)
;;=3^Carcinoma in Situ of Cervix
;;^UTILITY(U,$J,358.3,34363,1,4,0)
;;=4^D06.9
;;^UTILITY(U,$J,358.3,34363,2)
;;=^5001941
;;^UTILITY(U,$J,358.3,34364,0)
;;=D06.0^^105^1433^47
;;^UTILITY(U,$J,358.3,34364,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34364,1,3,0)
;;=3^Carcinoma in Situ of Endocervix
;;^UTILITY(U,$J,358.3,34364,1,4,0)
;;=4^D06.0
;;^UTILITY(U,$J,358.3,34364,2)
;;=^5001938
;;^UTILITY(U,$J,358.3,34365,0)
;;=D06.1^^105^1433^48
;;^UTILITY(U,$J,358.3,34365,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34365,1,3,0)
;;=3^Carcinoma in Situ of Exocervix
;;^UTILITY(U,$J,358.3,34365,1,4,0)
;;=4^D06.1
;;^UTILITY(U,$J,358.3,34365,2)
;;=^5001939
;;^UTILITY(U,$J,358.3,34366,0)
;;=D06.7^^105^1433^46
;;^UTILITY(U,$J,358.3,34366,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34366,1,3,0)
;;=3^Carcinoma in Situ of Cervix,Other Parts
;;^UTILITY(U,$J,358.3,34366,1,4,0)
;;=4^D06.7
;;^UTILITY(U,$J,358.3,34366,2)
;;=^5001940
;;^UTILITY(U,$J,358.3,34367,0)
;;=D04.9^^105^1433^49
;;^UTILITY(U,$J,358.3,34367,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,34367,1,3,0)
;;=3^Carcinoma in Situ of Skin
;;^UTILITY(U,$J,358.3,34367,1,4,0)
;;=4^D04.9
;;^UTILITY(U,$J,358.3,34367,2)
;;=^5001925
;;^UTILITY(U,$J,358.3,34368,0)
;;=C91.11^^105^1433^52
;;^UTILITY(U,$J,358.3,34368,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0DO 19751 printed Nov 22, 2024@16:56:50 Page 2
IBDEI0DO ; ; 03-MAY-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 03, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,34300,2)
+2 ;;=^5159288
+3 ;;^UTILITY(U,$J,358.3,34301,0)
+4 ;;=G44.1^^105^1431^10
+5 ;;^UTILITY(U,$J,358.3,34301,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,34301,1,3,0)
+8 ;;=3^Vascular Headache NEC
+9 ;;^UTILITY(U,$J,358.3,34301,1,4,0)
+10 ;;=4^G44.1
+11 ;;^UTILITY(U,$J,358.3,34301,2)
+12 ;;=^5003934
+13 ;;^UTILITY(U,$J,358.3,34302,0)
+14 ;;=G43.909^^105^1431^6
+15 ;;^UTILITY(U,$J,358.3,34302,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,34302,1,3,0)
+18 ;;=3^Migraine,Unspec,Not Intractable
+19 ;;^UTILITY(U,$J,358.3,34302,1,4,0)
+20 ;;=4^G43.909
+21 ;;^UTILITY(U,$J,358.3,34302,2)
+22 ;;=^5003909
+23 ;;^UTILITY(U,$J,358.3,34303,0)
+24 ;;=G44.009^^105^1431^1
+25 ;;^UTILITY(U,$J,358.3,34303,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,34303,1,3,0)
+28 ;;=3^Cluster Headache,Unspec,Not Intractable
+29 ;;^UTILITY(U,$J,358.3,34303,1,4,0)
+30 ;;=4^G44.009
+31 ;;^UTILITY(U,$J,358.3,34303,2)
+32 ;;=^5003921
+33 ;;^UTILITY(U,$J,358.3,34304,0)
+34 ;;=G44.40^^105^1431^5
+35 ;;^UTILITY(U,$J,358.3,34304,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,34304,1,3,0)
+38 ;;=3^Medication Overuse Headache,Not Intractable
+39 ;;^UTILITY(U,$J,358.3,34304,1,4,0)
+40 ;;=4^G44.40
+41 ;;^UTILITY(U,$J,358.3,34304,2)
+42 ;;=^5003947
+43 ;;^UTILITY(U,$J,358.3,34305,0)
+44 ;;=G44.89^^105^1431^2
+45 ;;^UTILITY(U,$J,358.3,34305,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,34305,1,3,0)
+48 ;;=3^Headache Syndrome NEC
+49 ;;^UTILITY(U,$J,358.3,34305,1,4,0)
+50 ;;=4^G44.89
+51 ;;^UTILITY(U,$J,358.3,34305,2)
+52 ;;=^5003954
+53 ;;^UTILITY(U,$J,358.3,34306,0)
+54 ;;=G44.84^^105^1431^8
+55 ;;^UTILITY(U,$J,358.3,34306,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,34306,1,3,0)
+58 ;;=3^Primary Exertional Headache
+59 ;;^UTILITY(U,$J,358.3,34306,1,4,0)
+60 ;;=4^G44.84
+61 ;;^UTILITY(U,$J,358.3,34306,2)
+62 ;;=^336563
+63 ;;^UTILITY(U,$J,358.3,34307,0)
+64 ;;=G44.301^^105^1431^7
+65 ;;^UTILITY(U,$J,358.3,34307,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,34307,1,3,0)
+68 ;;=3^Post-Traumatic Headache,Unspec,Intractable
+69 ;;^UTILITY(U,$J,358.3,34307,1,4,0)
+70 ;;=4^G44.301
+71 ;;^UTILITY(U,$J,358.3,34307,2)
+72 ;;=^5003941
+73 ;;^UTILITY(U,$J,358.3,34308,0)
+74 ;;=G44.209^^105^1431^9
+75 ;;^UTILITY(U,$J,358.3,34308,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,34308,1,3,0)
+78 ;;=3^Tension-Type Headache,Unspec,Not Intractable
+79 ;;^UTILITY(U,$J,358.3,34308,1,4,0)
+80 ;;=4^G44.209
+81 ;;^UTILITY(U,$J,358.3,34308,2)
+82 ;;=^5003936
+83 ;;^UTILITY(U,$J,358.3,34309,0)
+84 ;;=R51.0^^105^1431^3
+85 ;;^UTILITY(U,$J,358.3,34309,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,34309,1,3,0)
+88 ;;=3^Headache w/ Orthostatic Component,NEC
+89 ;;^UTILITY(U,$J,358.3,34309,1,4,0)
+90 ;;=4^R51.0
+91 ;;^UTILITY(U,$J,358.3,34309,2)
+92 ;;=^5159305
+93 ;;^UTILITY(U,$J,358.3,34310,0)
+94 ;;=R51.9^^105^1431^4
+95 ;;^UTILITY(U,$J,358.3,34310,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,34310,1,3,0)
+98 ;;=3^Headache,Unspec
+99 ;;^UTILITY(U,$J,358.3,34310,1,4,0)
+100 ;;=4^R51.9
+101 ;;^UTILITY(U,$J,358.3,34310,2)
+102 ;;=^5159306
+103 ;;^UTILITY(U,$J,358.3,34311,0)
+104 ;;=I30.0^^105^1432^5
+105 ;;^UTILITY(U,$J,358.3,34311,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,34311,1,3,0)
+108 ;;=3^Idiopathic Pericarditis,Acute Nonspec
+109 ;;^UTILITY(U,$J,358.3,34311,1,4,0)
+110 ;;=4^I30.0
+111 ;;^UTILITY(U,$J,358.3,34311,2)
+112 ;;=^5007157
+113 ;;^UTILITY(U,$J,358.3,34312,0)
+114 ;;=I34.8^^105^1432^6
+115 ;;^UTILITY(U,$J,358.3,34312,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,34312,1,3,0)
+118 ;;=3^Mitral Valve Disorders,Nonrheumatic Other
+119 ;;^UTILITY(U,$J,358.3,34312,1,4,0)
+120 ;;=4^I34.8
+121 ;;^UTILITY(U,$J,358.3,34312,2)
+122 ;;=^5007172
+123 ;;^UTILITY(U,$J,358.3,34313,0)
+124 ;;=I34.0^^105^1432^13
+125 ;;^UTILITY(U,$J,358.3,34313,1,0)
+126 ;;=^358.31IA^4^2
+127 ;;^UTILITY(U,$J,358.3,34313,1,3,0)
+128 ;;=3^Nonrheumatic Mitral Valve Insufficiency
+129 ;;^UTILITY(U,$J,358.3,34313,1,4,0)
+130 ;;=4^I34.0
+131 ;;^UTILITY(U,$J,358.3,34313,2)
+132 ;;=^5007169
+133 ;;^UTILITY(U,$J,358.3,34314,0)
+134 ;;=I34.9^^105^1432^12
+135 ;;^UTILITY(U,$J,358.3,34314,1,0)
+136 ;;=^358.31IA^4^2
+137 ;;^UTILITY(U,$J,358.3,34314,1,3,0)
+138 ;;=3^Nonrheumatic Mitral Valve Disorder,Unspec
+139 ;;^UTILITY(U,$J,358.3,34314,1,4,0)
+140 ;;=4^I34.9
+141 ;;^UTILITY(U,$J,358.3,34314,2)
+142 ;;=^5007173
+143 ;;^UTILITY(U,$J,358.3,34315,0)
+144 ;;=I34.2^^105^1432^7
+145 ;;^UTILITY(U,$J,358.3,34315,1,0)
+146 ;;=^358.31IA^4^2
+147 ;;^UTILITY(U,$J,358.3,34315,1,3,0)
+148 ;;=3^Nonrhematic Mitral Valve Stenosis
+149 ;;^UTILITY(U,$J,358.3,34315,1,4,0)
+150 ;;=4^I34.2
+151 ;;^UTILITY(U,$J,358.3,34315,2)
+152 ;;=^5007171
+153 ;;^UTILITY(U,$J,358.3,34316,0)
+154 ;;=I35.0^^105^1432^10
+155 ;;^UTILITY(U,$J,358.3,34316,1,0)
+156 ;;=^358.31IA^4^2
+157 ;;^UTILITY(U,$J,358.3,34316,1,3,0)
+158 ;;=3^Nonrheumatic Aortic Valve Stenosis
+159 ;;^UTILITY(U,$J,358.3,34316,1,4,0)
+160 ;;=4^I35.0
+161 ;;^UTILITY(U,$J,358.3,34316,2)
+162 ;;=^5007174
+163 ;;^UTILITY(U,$J,358.3,34317,0)
+164 ;;=I35.1^^105^1432^9
+165 ;;^UTILITY(U,$J,358.3,34317,1,0)
+166 ;;=^358.31IA^4^2
+167 ;;^UTILITY(U,$J,358.3,34317,1,3,0)
+168 ;;=3^Nonrheumatic Aortic Valve Insufficiency
+169 ;;^UTILITY(U,$J,358.3,34317,1,4,0)
+170 ;;=4^I35.1
+171 ;;^UTILITY(U,$J,358.3,34317,2)
+172 ;;=^5007175
+173 ;;^UTILITY(U,$J,358.3,34318,0)
+174 ;;=I35.2^^105^1432^11
+175 ;;^UTILITY(U,$J,358.3,34318,1,0)
+176 ;;=^358.31IA^4^2
+177 ;;^UTILITY(U,$J,358.3,34318,1,3,0)
+178 ;;=3^Nonrheumatic Aortic Valve Stenosis w/ Insufficiency
+179 ;;^UTILITY(U,$J,358.3,34318,1,4,0)
+180 ;;=4^I35.2
+181 ;;^UTILITY(U,$J,358.3,34318,2)
+182 ;;=^5007176
+183 ;;^UTILITY(U,$J,358.3,34319,0)
+184 ;;=I35.9^^105^1432^8
+185 ;;^UTILITY(U,$J,358.3,34319,1,0)
+186 ;;=^358.31IA^4^2
+187 ;;^UTILITY(U,$J,358.3,34319,1,3,0)
+188 ;;=3^Nonrheumatic Aortic Valve Disorder,Unspec
+189 ;;^UTILITY(U,$J,358.3,34319,1,4,0)
+190 ;;=4^I35.9
+191 ;;^UTILITY(U,$J,358.3,34319,2)
+192 ;;=^5007178
+193 ;;^UTILITY(U,$J,358.3,34320,0)
+194 ;;=I38.^^105^1432^4
+195 ;;^UTILITY(U,$J,358.3,34320,1,0)
+196 ;;=^358.31IA^4^2
+197 ;;^UTILITY(U,$J,358.3,34320,1,3,0)
+198 ;;=3^Endocarditis,Valve Unspec
+199 ;;^UTILITY(U,$J,358.3,34320,1,4,0)
+200 ;;=4^I38.
+201 ;;^UTILITY(U,$J,358.3,34320,2)
+202 ;;=^40327
+203 ;;^UTILITY(U,$J,358.3,34321,0)
+204 ;;=I05.0^^105^1432^18
+205 ;;^UTILITY(U,$J,358.3,34321,1,0)
+206 ;;=^358.31IA^4^2
+207 ;;^UTILITY(U,$J,358.3,34321,1,3,0)
+208 ;;=3^Rheumatic Mitral Stenosis
+209 ;;^UTILITY(U,$J,358.3,34321,1,4,0)
+210 ;;=4^I05.0
+211 ;;^UTILITY(U,$J,358.3,34321,2)
+212 ;;=^5007041
+213 ;;^UTILITY(U,$J,358.3,34322,0)
+214 ;;=I05.8^^105^1432^19
+215 ;;^UTILITY(U,$J,358.3,34322,1,0)
+216 ;;=^358.31IA^4^2
+217 ;;^UTILITY(U,$J,358.3,34322,1,3,0)
+218 ;;=3^Rheumatic Mitral Valve Disease NEC
+219 ;;^UTILITY(U,$J,358.3,34322,1,4,0)
+220 ;;=4^I05.8
+221 ;;^UTILITY(U,$J,358.3,34322,2)
+222 ;;=^5007043
+223 ;;^UTILITY(U,$J,358.3,34323,0)
+224 ;;=I05.9^^105^1432^20
+225 ;;^UTILITY(U,$J,358.3,34323,1,0)
+226 ;;=^358.31IA^4^2
+227 ;;^UTILITY(U,$J,358.3,34323,1,3,0)
+228 ;;=3^Rheumatic Mitral Valve Disease,Unspec
+229 ;;^UTILITY(U,$J,358.3,34323,1,4,0)
+230 ;;=4^I05.9
+231 ;;^UTILITY(U,$J,358.3,34323,2)
+232 ;;=^5007044
+233 ;;^UTILITY(U,$J,358.3,34324,0)
+234 ;;=I07.1^^105^1432^21
+235 ;;^UTILITY(U,$J,358.3,34324,1,0)
+236 ;;=^358.31IA^4^2
+237 ;;^UTILITY(U,$J,358.3,34324,1,3,0)
+238 ;;=3^Rheumatic Tricuspid Insufficiency
+239 ;;^UTILITY(U,$J,358.3,34324,1,4,0)
+240 ;;=4^I07.1
+241 ;;^UTILITY(U,$J,358.3,34324,2)
+242 ;;=^5007048
+243 ;;^UTILITY(U,$J,358.3,34325,0)
+244 ;;=I07.9^^105^1432^22
+245 ;;^UTILITY(U,$J,358.3,34325,1,0)
+246 ;;=^358.31IA^4^2
+247 ;;^UTILITY(U,$J,358.3,34325,1,3,0)
+248 ;;=3^Rheumatic Tricuspid Valve Disease,Unspec
+249 ;;^UTILITY(U,$J,358.3,34325,1,4,0)
+250 ;;=4^I07.9
+251 ;;^UTILITY(U,$J,358.3,34325,2)
+252 ;;=^5007051
+253 ;;^UTILITY(U,$J,358.3,34326,0)
+254 ;;=I08.0^^105^1432^16
+255 ;;^UTILITY(U,$J,358.3,34326,1,0)
+256 ;;=^358.31IA^4^2
+257 ;;^UTILITY(U,$J,358.3,34326,1,3,0)
+258 ;;=3^Rheumatic Disorders of Mitral & Aortic Valves
+259 ;;^UTILITY(U,$J,358.3,34326,1,4,0)
+260 ;;=4^I08.0
+261 ;;^UTILITY(U,$J,358.3,34326,2)
+262 ;;=^5007052
+263 ;;^UTILITY(U,$J,358.3,34327,0)
+264 ;;=I09.89^^105^1432^17
+265 ;;^UTILITY(U,$J,358.3,34327,1,0)
+266 ;;=^358.31IA^4^2
+267 ;;^UTILITY(U,$J,358.3,34327,1,3,0)
+268 ;;=3^Rheumatic Heart Diseases NEC
+269 ;;^UTILITY(U,$J,358.3,34327,1,4,0)
+270 ;;=4^I09.89
+271 ;;^UTILITY(U,$J,358.3,34327,2)
+272 ;;=^5007060
+273 ;;^UTILITY(U,$J,358.3,34328,0)
+274 ;;=I47.1^^105^1432^24
+275 ;;^UTILITY(U,$J,358.3,34328,1,0)
+276 ;;=^358.31IA^4^2
+277 ;;^UTILITY(U,$J,358.3,34328,1,3,0)
+278 ;;=3^Supraventricular Tachycardia
+279 ;;^UTILITY(U,$J,358.3,34328,1,4,0)
+280 ;;=4^I47.1
+281 ;;^UTILITY(U,$J,358.3,34328,2)
+282 ;;=^5007223
+283 ;;^UTILITY(U,$J,358.3,34329,0)
+284 ;;=I48.0^^105^1432^15
+285 ;;^UTILITY(U,$J,358.3,34329,1,0)
+286 ;;=^358.31IA^4^2
+287 ;;^UTILITY(U,$J,358.3,34329,1,3,0)
+288 ;;=3^Paroxysmal Atrial Fibrillation
+289 ;;^UTILITY(U,$J,358.3,34329,1,4,0)
+290 ;;=4^I48.0
+291 ;;^UTILITY(U,$J,358.3,34329,2)
+292 ;;=^90473
+293 ;;^UTILITY(U,$J,358.3,34330,0)
+294 ;;=I49.5^^105^1432^23
+295 ;;^UTILITY(U,$J,358.3,34330,1,0)
+296 ;;=^358.31IA^4^2
+297 ;;^UTILITY(U,$J,358.3,34330,1,3,0)
+298 ;;=3^Sick Sinus Syndrome
+299 ;;^UTILITY(U,$J,358.3,34330,1,4,0)
+300 ;;=4^I49.5
+301 ;;^UTILITY(U,$J,358.3,34330,2)
+302 ;;=^110404
+303 ;;^UTILITY(U,$J,358.3,34331,0)
+304 ;;=I49.8^^105^1432^3
+305 ;;^UTILITY(U,$J,358.3,34331,1,0)
+306 ;;=^358.31IA^4^2
+307 ;;^UTILITY(U,$J,358.3,34331,1,3,0)
+308 ;;=3^Cardiac Arrhythmias
+309 ;;^UTILITY(U,$J,358.3,34331,1,4,0)
+310 ;;=4^I49.8
+311 ;;^UTILITY(U,$J,358.3,34331,2)
+312 ;;=^5007236
+313 ;;^UTILITY(U,$J,358.3,34332,0)
+314 ;;=I49.9^^105^1432^2
+315 ;;^UTILITY(U,$J,358.3,34332,1,0)
+316 ;;=^358.31IA^4^2
+317 ;;^UTILITY(U,$J,358.3,34332,1,3,0)
+318 ;;=3^Cardiac Arrhythmia,Unspec
+319 ;;^UTILITY(U,$J,358.3,34332,1,4,0)
+320 ;;=4^I49.9
+321 ;;^UTILITY(U,$J,358.3,34332,2)
+322 ;;=^5007237
+323 ;;^UTILITY(U,$J,358.3,34333,0)
+324 ;;=R00.1^^105^1432^1
+325 ;;^UTILITY(U,$J,358.3,34333,1,0)
+326 ;;=^358.31IA^4^2
+327 ;;^UTILITY(U,$J,358.3,34333,1,3,0)
+328 ;;=3^Bradycardia,Unspec
+329 ;;^UTILITY(U,$J,358.3,34333,1,4,0)
+330 ;;=4^R00.1
+331 ;;^UTILITY(U,$J,358.3,34333,2)
+332 ;;=^5019164
+333 ;;^UTILITY(U,$J,358.3,34334,0)
+334 ;;=I34.1^^105^1432^14
+335 ;;^UTILITY(U,$J,358.3,34334,1,0)
+336 ;;=^358.31IA^4^2
+337 ;;^UTILITY(U,$J,358.3,34334,1,3,0)
+338 ;;=3^Nonrheumatic Mitral Valve Prolapse
+339 ;;^UTILITY(U,$J,358.3,34334,1,4,0)
+340 ;;=4^I34.1
+341 ;;^UTILITY(U,$J,358.3,34334,2)
+342 ;;=^5007170
+343 ;;^UTILITY(U,$J,358.3,34335,0)
+344 ;;=D68.4^^105^1433^1
+345 ;;^UTILITY(U,$J,358.3,34335,1,0)
+346 ;;=^358.31IA^4^2
+347 ;;^UTILITY(U,$J,358.3,34335,1,3,0)
+348 ;;=3^Acquired Coagulation Factor Deficiency
+349 ;;^UTILITY(U,$J,358.3,34335,1,4,0)
+350 ;;=4^D68.4
+351 ;;^UTILITY(U,$J,358.3,34335,2)
+352 ;;=^2235
+353 ;;^UTILITY(U,$J,358.3,34336,0)
+354 ;;=D59.9^^105^1433^2
+355 ;;^UTILITY(U,$J,358.3,34336,1,0)
+356 ;;=^358.31IA^4^2
+357 ;;^UTILITY(U,$J,358.3,34336,1,3,0)
+358 ;;=3^Acquired Hemolytic Anemia,Unspec
+359 ;;^UTILITY(U,$J,358.3,34336,1,4,0)
+360 ;;=4^D59.9
+361 ;;^UTILITY(U,$J,358.3,34336,2)
+362 ;;=^5002330
+363 ;;^UTILITY(U,$J,358.3,34337,0)
+364 ;;=C91.00^^105^1433^5
+365 ;;^UTILITY(U,$J,358.3,34337,1,0)
+366 ;;=^358.31IA^4^2
+367 ;;^UTILITY(U,$J,358.3,34337,1,3,0)
+368 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
+369 ;;^UTILITY(U,$J,358.3,34337,1,4,0)
+370 ;;=4^C91.00
+371 ;;^UTILITY(U,$J,358.3,34337,2)
+372 ;;=^5001762
+373 ;;^UTILITY(U,$J,358.3,34338,0)
+374 ;;=C91.01^^105^1433^4
+375 ;;^UTILITY(U,$J,358.3,34338,1,0)
+376 ;;=^358.31IA^4^2
+377 ;;^UTILITY(U,$J,358.3,34338,1,3,0)
+378 ;;=3^Acute Lymphoblastic Leukemia,In Remission
+379 ;;^UTILITY(U,$J,358.3,34338,1,4,0)
+380 ;;=4^C91.01
+381 ;;^UTILITY(U,$J,358.3,34338,2)
+382 ;;=^5001763
+383 ;;^UTILITY(U,$J,358.3,34339,0)
+384 ;;=C92.01^^105^1433^7
+385 ;;^UTILITY(U,$J,358.3,34339,1,0)
+386 ;;=^358.31IA^4^2
+387 ;;^UTILITY(U,$J,358.3,34339,1,3,0)
+388 ;;=3^Acute Myeloblastic Leukemia,In Remission
+389 ;;^UTILITY(U,$J,358.3,34339,1,4,0)
+390 ;;=4^C92.01
+391 ;;^UTILITY(U,$J,358.3,34339,2)
+392 ;;=^5001790
+393 ;;^UTILITY(U,$J,358.3,34340,0)
+394 ;;=C92.00^^105^1433^8
+395 ;;^UTILITY(U,$J,358.3,34340,1,0)
+396 ;;=^358.31IA^4^2
+397 ;;^UTILITY(U,$J,358.3,34340,1,3,0)
+398 ;;=3^Acute Myeloblastic Leukemia,Not in Remission
+399 ;;^UTILITY(U,$J,358.3,34340,1,4,0)
+400 ;;=4^C92.00
+401 ;;^UTILITY(U,$J,358.3,34340,2)
+402 ;;=^5001789
+403 ;;^UTILITY(U,$J,358.3,34341,0)
+404 ;;=C92.61^^105^1433^9
+405 ;;^UTILITY(U,$J,358.3,34341,1,0)
+406 ;;=^358.31IA^4^2
+407 ;;^UTILITY(U,$J,358.3,34341,1,3,0)
+408 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,In Remission
+409 ;;^UTILITY(U,$J,358.3,34341,1,4,0)
+410 ;;=4^C92.61
+411 ;;^UTILITY(U,$J,358.3,34341,2)
+412 ;;=^5001808
+413 ;;^UTILITY(U,$J,358.3,34342,0)
+414 ;;=C92.60^^105^1433^10
+415 ;;^UTILITY(U,$J,358.3,34342,1,0)
+416 ;;=^358.31IA^4^2
+417 ;;^UTILITY(U,$J,358.3,34342,1,3,0)
+418 ;;=3^Acute Myeloid Leukemia w/ 11q23-Abnormality,Not in Remission
+419 ;;^UTILITY(U,$J,358.3,34342,1,4,0)
+420 ;;=4^C92.60
+421 ;;^UTILITY(U,$J,358.3,34342,2)
+422 ;;=^5001807
+423 ;;^UTILITY(U,$J,358.3,34343,0)
+424 ;;=C92.A1^^105^1433^11
+425 ;;^UTILITY(U,$J,358.3,34343,1,0)
+426 ;;=^358.31IA^4^2
+427 ;;^UTILITY(U,$J,358.3,34343,1,3,0)
+428 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,In Remission
+429 ;;^UTILITY(U,$J,358.3,34343,1,4,0)
+430 ;;=4^C92.A1
+431 ;;^UTILITY(U,$J,358.3,34343,2)
+432 ;;=^5001814
+433 ;;^UTILITY(U,$J,358.3,34344,0)
+434 ;;=C92.A0^^105^1433^12
+435 ;;^UTILITY(U,$J,358.3,34344,1,0)
+436 ;;=^358.31IA^4^2
+437 ;;^UTILITY(U,$J,358.3,34344,1,3,0)
+438 ;;=3^Acute Myeloid Leukemia w/ Multilin Dysplasia,Not in Remission
+439 ;;^UTILITY(U,$J,358.3,34344,1,4,0)
+440 ;;=4^C92.A0
+441 ;;^UTILITY(U,$J,358.3,34344,2)
+442 ;;=^5001813
+443 ;;^UTILITY(U,$J,358.3,34345,0)
+444 ;;=C92.51^^105^1433^13
+445 ;;^UTILITY(U,$J,358.3,34345,1,0)
+446 ;;=^358.31IA^4^2
+447 ;;^UTILITY(U,$J,358.3,34345,1,3,0)
+448 ;;=3^Acute Myelomonocytic Leukemia,In Remission
+449 ;;^UTILITY(U,$J,358.3,34345,1,4,0)
+450 ;;=4^C92.51
+451 ;;^UTILITY(U,$J,358.3,34345,2)
+452 ;;=^5001805
+453 ;;^UTILITY(U,$J,358.3,34346,0)
+454 ;;=C92.50^^105^1433^14
+455 ;;^UTILITY(U,$J,358.3,34346,1,0)
+456 ;;=^358.31IA^4^2
+457 ;;^UTILITY(U,$J,358.3,34346,1,3,0)
+458 ;;=3^Acute Myelomonocytic Leukemia,Not in Remission
+459 ;;^UTILITY(U,$J,358.3,34346,1,4,0)
+460 ;;=4^C92.50
+461 ;;^UTILITY(U,$J,358.3,34346,2)
+462 ;;=^5001804
+463 ;;^UTILITY(U,$J,358.3,34347,0)
+464 ;;=C94.40^^105^1433^17
+465 ;;^UTILITY(U,$J,358.3,34347,1,0)
+466 ;;=^358.31IA^4^2
+467 ;;^UTILITY(U,$J,358.3,34347,1,3,0)
+468 ;;=3^Acute Panmyelosis w/ Myelofibrosis,Not in Remission
+469 ;;^UTILITY(U,$J,358.3,34347,1,4,0)
+470 ;;=4^C94.40
+471 ;;^UTILITY(U,$J,358.3,34347,2)
+472 ;;=^5001843
+473 ;;^UTILITY(U,$J,358.3,34348,0)
+474 ;;=C94.42^^105^1433^15
+475 ;;^UTILITY(U,$J,358.3,34348,1,0)
+476 ;;=^358.31IA^4^2
+477 ;;^UTILITY(U,$J,358.3,34348,1,3,0)
+478 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
+479 ;;^UTILITY(U,$J,358.3,34348,1,4,0)
+480 ;;=4^C94.42
+481 ;;^UTILITY(U,$J,358.3,34348,2)
+482 ;;=^5001845
+483 ;;^UTILITY(U,$J,358.3,34349,0)
+484 ;;=C94.41^^105^1433^16
+485 ;;^UTILITY(U,$J,358.3,34349,1,0)
+486 ;;=^358.31IA^4^2
+487 ;;^UTILITY(U,$J,358.3,34349,1,3,0)
+488 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
+489 ;;^UTILITY(U,$J,358.3,34349,1,4,0)
+490 ;;=4^C94.41
+491 ;;^UTILITY(U,$J,358.3,34349,2)
+492 ;;=^5001844
+493 ;;^UTILITY(U,$J,358.3,34350,0)
+494 ;;=D62.^^105^1433^18
+495 ;;^UTILITY(U,$J,358.3,34350,1,0)
+496 ;;=^358.31IA^4^2
+497 ;;^UTILITY(U,$J,358.3,34350,1,3,0)
+498 ;;=3^Acute Posthemorrhagic Anemia
+499 ;;^UTILITY(U,$J,358.3,34350,1,4,0)
+500 ;;=4^D62.
+501 ;;^UTILITY(U,$J,358.3,34350,2)
+502 ;;=^267986
+503 ;;^UTILITY(U,$J,358.3,34351,0)
+504 ;;=C92.41^^105^1433^19
+505 ;;^UTILITY(U,$J,358.3,34351,1,0)
+506 ;;=^358.31IA^4^2
+507 ;;^UTILITY(U,$J,358.3,34351,1,3,0)
+508 ;;=3^Acute Promyelocytic Leukemia,In Remission
+509 ;;^UTILITY(U,$J,358.3,34351,1,4,0)
+510 ;;=4^C92.41
+511 ;;^UTILITY(U,$J,358.3,34351,2)
+512 ;;=^5001802
+513 ;;^UTILITY(U,$J,358.3,34352,0)
+514 ;;=C92.40^^105^1433^20
+515 ;;^UTILITY(U,$J,358.3,34352,1,0)
+516 ;;=^358.31IA^4^2
+517 ;;^UTILITY(U,$J,358.3,34352,1,3,0)
+518 ;;=3^Acute Promyelocytic Leukemia,Not in Remission
+519 ;;^UTILITY(U,$J,358.3,34352,1,4,0)
+520 ;;=4^C92.40
+521 ;;^UTILITY(U,$J,358.3,34352,2)
+522 ;;=^5001801
+523 ;;^UTILITY(U,$J,358.3,34353,0)
+524 ;;=D56.0^^105^1433^21
+525 ;;^UTILITY(U,$J,358.3,34353,1,0)
+526 ;;=^358.31IA^4^2
+527 ;;^UTILITY(U,$J,358.3,34353,1,3,0)
+528 ;;=3^Alpha Thalassemia
+529 ;;^UTILITY(U,$J,358.3,34353,1,4,0)
+530 ;;=4^D56.0
+531 ;;^UTILITY(U,$J,358.3,34353,2)
+532 ;;=^340494
+533 ;;^UTILITY(U,$J,358.3,34354,0)
+534 ;;=D63.1^^105^1433^23
+535 ;;^UTILITY(U,$J,358.3,34354,1,0)
+536 ;;=^358.31IA^4^2
+537 ;;^UTILITY(U,$J,358.3,34354,1,3,0)
+538 ;;=3^Anemia in Chronic Kidney Disease
+539 ;;^UTILITY(U,$J,358.3,34354,1,4,0)
+540 ;;=4^D63.1
+541 ;;^UTILITY(U,$J,358.3,34354,2)
+542 ;;=^332908
+543 ;;^UTILITY(U,$J,358.3,34355,0)
+544 ;;=D63.0^^105^1433^24
+545 ;;^UTILITY(U,$J,358.3,34355,1,0)
+546 ;;=^358.31IA^4^2
+547 ;;^UTILITY(U,$J,358.3,34355,1,3,0)
+548 ;;=3^Anemia in Neoplastic Disease
+549 ;;^UTILITY(U,$J,358.3,34355,1,4,0)
+550 ;;=4^D63.0
+551 ;;^UTILITY(U,$J,358.3,34355,2)
+552 ;;=^321978
+553 ;;^UTILITY(U,$J,358.3,34356,0)
+554 ;;=D63.8^^105^1433^22
+555 ;;^UTILITY(U,$J,358.3,34356,1,0)
+556 ;;=^358.31IA^4^2
+557 ;;^UTILITY(U,$J,358.3,34356,1,3,0)
+558 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
+559 ;;^UTILITY(U,$J,358.3,34356,1,4,0)
+560 ;;=4^D63.8
+561 ;;^UTILITY(U,$J,358.3,34356,2)
+562 ;;=^5002343
+563 ;;^UTILITY(U,$J,358.3,34357,0)
+564 ;;=C22.3^^105^1433^27
+565 ;;^UTILITY(U,$J,358.3,34357,1,0)
+566 ;;=^358.31IA^4^2
+567 ;;^UTILITY(U,$J,358.3,34357,1,3,0)
+568 ;;=3^Angiosarcoma of Liver
+569 ;;^UTILITY(U,$J,358.3,34357,1,4,0)
+570 ;;=4^C22.3
+571 ;;^UTILITY(U,$J,358.3,34357,2)
+572 ;;=^5000936
+573 ;;^UTILITY(U,$J,358.3,34358,0)
+574 ;;=D61.9^^105^1433^28
+575 ;;^UTILITY(U,$J,358.3,34358,1,0)
+576 ;;=^358.31IA^4^2
+577 ;;^UTILITY(U,$J,358.3,34358,1,3,0)
+578 ;;=3^Aplastic Anemia,Unspec
+579 ;;^UTILITY(U,$J,358.3,34358,1,4,0)
+580 ;;=4^D61.9
+581 ;;^UTILITY(U,$J,358.3,34358,2)
+582 ;;=^5002342
+583 ;;^UTILITY(U,$J,358.3,34359,0)
+584 ;;=D56.1^^105^1433^34
+585 ;;^UTILITY(U,$J,358.3,34359,1,0)
+586 ;;=^358.31IA^4^2
+587 ;;^UTILITY(U,$J,358.3,34359,1,3,0)
+588 ;;=3^Beta Thalassemia
+589 ;;^UTILITY(U,$J,358.3,34359,1,4,0)
+590 ;;=4^D56.1
+591 ;;^UTILITY(U,$J,358.3,34359,2)
+592 ;;=^340495
+593 ;;^UTILITY(U,$J,358.3,34360,0)
+594 ;;=C83.79^^105^1433^36
+595 ;;^UTILITY(U,$J,358.3,34360,1,0)
+596 ;;=^358.31IA^4^2
+597 ;;^UTILITY(U,$J,358.3,34360,1,3,0)
+598 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
+599 ;;^UTILITY(U,$J,358.3,34360,1,4,0)
+600 ;;=4^C83.79
+601 ;;^UTILITY(U,$J,358.3,34360,2)
+602 ;;=^5001600
+603 ;;^UTILITY(U,$J,358.3,34361,0)
+604 ;;=C83.70^^105^1433^37
+605 ;;^UTILITY(U,$J,358.3,34361,1,0)
+606 ;;=^358.31IA^4^2
+607 ;;^UTILITY(U,$J,358.3,34361,1,3,0)
+608 ;;=3^Burkitt Lymphoma,Unspec Site
+609 ;;^UTILITY(U,$J,358.3,34361,1,4,0)
+610 ;;=4^C83.70
+611 ;;^UTILITY(U,$J,358.3,34361,2)
+612 ;;=^5001591
+613 ;;^UTILITY(U,$J,358.3,34362,0)
+614 ;;=D09.0^^105^1433^44
+615 ;;^UTILITY(U,$J,358.3,34362,1,0)
+616 ;;=^358.31IA^4^2
+617 ;;^UTILITY(U,$J,358.3,34362,1,3,0)
+618 ;;=3^Carcinoma in Situ of Bladder
+619 ;;^UTILITY(U,$J,358.3,34362,1,4,0)
+620 ;;=4^D09.0
+621 ;;^UTILITY(U,$J,358.3,34362,2)
+622 ;;=^267742
+623 ;;^UTILITY(U,$J,358.3,34363,0)
+624 ;;=D06.9^^105^1433^45
+625 ;;^UTILITY(U,$J,358.3,34363,1,0)
+626 ;;=^358.31IA^4^2
+627 ;;^UTILITY(U,$J,358.3,34363,1,3,0)
+628 ;;=3^Carcinoma in Situ of Cervix
+629 ;;^UTILITY(U,$J,358.3,34363,1,4,0)
+630 ;;=4^D06.9
+631 ;;^UTILITY(U,$J,358.3,34363,2)
+632 ;;=^5001941
+633 ;;^UTILITY(U,$J,358.3,34364,0)
+634 ;;=D06.0^^105^1433^47
+635 ;;^UTILITY(U,$J,358.3,34364,1,0)
+636 ;;=^358.31IA^4^2
+637 ;;^UTILITY(U,$J,358.3,34364,1,3,0)
+638 ;;=3^Carcinoma in Situ of Endocervix
+639 ;;^UTILITY(U,$J,358.3,34364,1,4,0)
+640 ;;=4^D06.0
+641 ;;^UTILITY(U,$J,358.3,34364,2)
+642 ;;=^5001938
+643 ;;^UTILITY(U,$J,358.3,34365,0)
+644 ;;=D06.1^^105^1433^48
+645 ;;^UTILITY(U,$J,358.3,34365,1,0)
+646 ;;=^358.31IA^4^2
+647 ;;^UTILITY(U,$J,358.3,34365,1,3,0)
+648 ;;=3^Carcinoma in Situ of Exocervix
+649 ;;^UTILITY(U,$J,358.3,34365,1,4,0)
+650 ;;=4^D06.1
+651 ;;^UTILITY(U,$J,358.3,34365,2)
+652 ;;=^5001939
+653 ;;^UTILITY(U,$J,358.3,34366,0)
+654 ;;=D06.7^^105^1433^46
+655 ;;^UTILITY(U,$J,358.3,34366,1,0)
+656 ;;=^358.31IA^4^2
+657 ;;^UTILITY(U,$J,358.3,34366,1,3,0)
+658 ;;=3^Carcinoma in Situ of Cervix,Other Parts
+659 ;;^UTILITY(U,$J,358.3,34366,1,4,0)
+660 ;;=4^D06.7
+661 ;;^UTILITY(U,$J,358.3,34366,2)
+662 ;;=^5001940
+663 ;;^UTILITY(U,$J,358.3,34367,0)
+664 ;;=D04.9^^105^1433^49
+665 ;;^UTILITY(U,$J,358.3,34367,1,0)
+666 ;;=^358.31IA^4^2
+667 ;;^UTILITY(U,$J,358.3,34367,1,3,0)
+668 ;;=3^Carcinoma in Situ of Skin
+669 ;;^UTILITY(U,$J,358.3,34367,1,4,0)
+670 ;;=4^D04.9
+671 ;;^UTILITY(U,$J,358.3,34367,2)
+672 ;;=^5001925
+673 ;;^UTILITY(U,$J,358.3,34368,0)
+674 ;;=C91.11^^105^1433^52
+675 ;;^UTILITY(U,$J,358.3,34368,1,0)
+676 ;;=^358.31IA^4^2
